Revenue
2022
2023
2024
2025
Rtw Biotech Opportunities Ltd (RTW)
Price$2.42Cached quote
Net income
2021
2022
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $250.9M | $38.7M | $86.3M | −$36.5M | N/A |
| Research & development | N/A | $849,452 | $474,511 | $742,738 | $237,984 |
| Operating expenses | $5.7M | $4.5M | $3.1M | $2.9M | N/A |
| Net income | $245.2M | $34.2M | $83.2M | −$39.4M | −$64.3M |
| Net profit margin | 97.73% | 88.25% | 96.40% | N/A | N/A |
| Basic EPSper basic share | $0.63 | $0.11 | $0.36 | -$0.17 | N/A |
| Diluted EPSper diluted share | $0.63 | $0.11 | $0.36 | -$0.17 | N/A |
Owners
Reported major voting-rights holders
9.96%of voting rights
Bluestem Asset Management, LLCNotified May 5, 2026
View holders
| Holder | Voting rights |
|---|---|
| 9.96%May 5, 2026 · 32.25M votes | |
| 3.07%Oct 6, 2026 · 9.87M votes |
These are threshold-crossing notices, not a complete ownership register. Percentages show issuer voting rights held through the listed share class, exclude financial instruments, and come from different dates. Positions may overlap.
Gray completes the 100% scale; it is not an estimate of other owners.
Source: FCA voting-rights notice ↗Updated Oct 21, 2026